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ABSTRAK 
 
Limfoma tiroid primer merupakan penyakit kanser yang jarang berlaku. Ia merangkumi 
2% daripada keseluruhan limfoma malignan dan kurang daripada 5% daripada limfoma 
tiroid. Ia adalah penyakit yang sangat agresif dan merbahaya. Kebanyakan limfoma ti-
roid terdiri daripada limfoma ‘non-Hodgkin’ yang berasal dari sel limfoid B. Majoriti kes-
kes berlaku dikalangan wanita enam puluhan. Kami melaporkan dua kes limfoma tiroid 
primer dengan memberi penekanan terhadap isu-isu klinikal dan kesulitan menangani 
penyakit ini. Kedua-dua pesakit datang ke hospital dengan kesukaran pernafasan yang 
memerlukan pembedahan. Keberkesanan radioterapi, kemoterapi, pembedahan dan 
penggunaan antibodi monoklonal masih lagi didebatkan. Peranan pembedahan di dalam 
menangani kes limfoma tiroid primer sudah banyak berubah namun peranannya yang 
penting di dalam kes-kes kecemasan tidak boleh diketepikan. Kedua-dua pesakit yang 
dilaporkan perlu menjalani pembedahan kecemasan tetapi hanya seorang sahaja yang 
telah menerima rawatan tambahan kemoterapi dan radioterapi. Kedua-dua kes ini me-
maparkan kesukaran di dalam pengurusan kes limfoma tiroid primer. 
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ABSTRACT  
 
Primary thyroid lymphoma is a rare disorder accounting for about 2% of all malignant 
lymphomas and less than 5% of thyroid malignancies. It is an aggressive disease with 
poor outcome. The majority of thyroid lymphomas are non-Hodgkin lymphomas of B-
cell origin. Majority of cases occur in women in the sixth decade. We report two cases 
of primary thyroid lymphoma and highlight the clinical issues and challenges posed by 
this rare disease. Both cases presented with respiratory obstructive symptoms that 
required surgical intervention. The optimal management for a primary thyroid lym-
phoma be it chemotherapy, radiotherapy, surgery or monoclonal antibodies is still de-
batable. The role for surgery has evolved through the years but its importance in 
emergency situations should not be overlooked. Both our patients had to undergo sur-
gery but only one patient received additional chemotherapy and radiotherapy. These 
two case reports illustrated the difficulties in managing this rare disorder. 
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INTRODUCTION 
 
Primary thyroid lymphoma is a rare dis-
order accounting for about 2% of all ma-
lignant lymphomas in general and less 
than 5% of thyroid malignancies (Sippel et 
al. 2002). Approximately 50-80% of pri-
mary thyroid lymphomas is of B-cell origin; 
which is the diffuse large cell type. The 
mucosa-associated lymphoid tissue 
(MALT) lymphomas, the more indolent 
lymphomas, account for 6 - 27% of thyroid 
lymphomas (Widder & Pasieka 2004). 
The most common clinical presentation of 
thyroid lymphoma is a rapidly enlarging 
thyroid mass associated with compressive 
symptoms (Sippel et al. 2002, Abdel et al. 
2001) namely dyspnea, dysphagia and 
pain. Patients are usually elderly with a 
peak incidence in the sixth decade (Ha et 
al. 2001) and have a female preponder-
ance (Sippel et al. 2002, Tupchong et al. 
1986, Charles et al. 2002). These tumours 
are noted to be almost always arising in 
the background of Hashimoto’s thyroiditis 
(Sippel et al. 2002).  
Management of thyroid lymphomas has 
evolved over the last 20 years from having 
the surgeons as major players for removal 
of obstructive symptoms to the more cur-
rent approach of non-invasive chemothe-
rapy and external beam radiation. Never-
theless, surgery still plays an important 
role as demonstrated by several studies 
(Sippel et al. 2002, Widder & Pasieka 
2004). Optimal treatment for primary thy-
roid lymphoma continues to be a colourful 
debate amongst clinicians. 
 
CASE REPORT  
 
Patient 1 
 
A 65-year-old Chinese man was referred 
for a progressively enlarging thyroid 
mass of 4 months’ duration, associated 
with hoarseness of voice and respiratory 
obstructive symptoms. He had no history 
of fever, night sweats, loss of weight or 
loss of appetite.  
On physical examination, he was a well 
built gentleman with a large neck swell-
ing. His blood pressure was 130/80 
mmHg and pulse rate was 90 per minute. 
There were multiple enlarged cervical 
lymph nodes but no other abnormalities 
were found. His full blood count and se-
rum biochemistry was normal except for 
a mild elevation of lactate dehydroge-
nase (LDH) levels (644 U/L). 
Assessment by the otolaryngologist re-
vealed a large multinodular goiter with 
retrosternal extension and bilateral vocal 
cord involvement. Fine needle aspiration 
cytology of the anterior thyroid swelling 
showed features consistent with poorly 
differentiated malignant tumour with pos-
sibilities that include malignant lymphoma 
and anaplastic carcinoma.  
Following the biopsy, he developed 
sudden onset of acute obstructive respi-
ratory symptoms which led to an emer-
gency debulking of his thyroid mass and 
tracheostomy. The histopathological ex-
amination of the thyroid tissue showed 
diffuse infiltration by large malignant cells 
arranged in sheets. The malignant cells 
exhibit pleomorphic vesicular nuclei and 
occasional prominent nucleoli. Immuno-
histochemically, the malignant cells ex-
pressed B cell markers (CD20 and 
CD79α) and were negative for creatinine 
kinase and T cell markers (CD3 and 
CD45Ro) and this confirmed the diagno-
sis of diffuse large B-cell lymphoma with 
extra thyroidal extension. 
Staging bone marrow aspiration and 
trephine biopsy showed no marrow infil-
tration by lymphoma cells. Computed 
tomography (CT) scan of the neck and 
thorax showed a large thyroid mass with 
retrosternal extension, multiple cervical 
lymphadenopathy, narrowing of the 
vocal cord and thickening of the larynx 
due to lymphomatous infiltration of the 
larynx.  
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The patient was started on chemothe-
rapy consisting of rituximab, cyclophos-
phamide, doxorubicin, vincristine and 
prednisolone (R-CHOP) two weeks after 
debulking of his tumour. During the post 
chemotherapy period, he developed up-
per gastro-intestinal bleeding, left tem-
poro-parietal infarct, and nosocomial 
pneumonia with Methicillin Resistant 
Staphylococcus aureus. However, he 
recovered from the complications after a 
prolonged stay in the hospital. After com-
pleting his sixth R-CHOP, a gallium scan 
was performed which showed an in-
creased in uptake in the right side of the 
superior mediastinum and hilar region. 
He was given another two cycles of R-
CHOP, but a repeat gallium scan showed 
persistent uptake with similar pattern and 
intensity and then radiotherapy was 
planned as the next choice of treatment 
for this patient. 
 
Patient 2 
 
A 68-year-old Malay lady who initially 
presented with a sudden increase in thy-
roid gland size, associated with pain and 
acute upper airway obstruction. An ur-
gent CT scan showed a thyroid mass 
with retrosternal extension and left inter-
nal jugular vein invasion with thrombosis. 
There was no mediastinal lymph node 
enlargement. She did not present with 
any B symptoms such as fever, night 
sweats or loss of significant body weight. 
An emergency modified radical neck dis-
section was performed and the left inter-
nal jugular vein was ligated. The histo-
pathological examination revealed diffuse 
large B-cell lymphoma of the thyroid 
gland (Figure 1). 
One week later, she developed left arm 
swelling and pain. An ultrasound Doppler 
showed evidence of left subclavian and 
axilary vein thrombosis. She was started 
on warfarin tablets 2 mg daily and was 
referred to our centre for chemotherapy. 
However, she only turned up at our hos-
pital two weeks later with dysphagia to 
solid food, neck swelling and left neck 
pain. Physical examination showed a 
large left neck swelling which was firm 
and tender. There was also a thyroidect-
omy scar present. Her blood pressure 
was 160/90 mmHg and her pulse rate 
was 95 beats per minute. Examination of 
other systems was normal. Her full blood 
count and serum biochemistry were nor-
mal except for a highly elevated lactate 
dehydrogenase level (> 12,000 U/L) and 
a slightly increased serum uric acid (577 
umol/L). Her thyroid function test showed 
hypothyroidism (free T4: <5.15 pmol/L, 
thyroid stimulating hormone: 69.41 
µIU/ml). No bone marrow assessment 
was done previously.   
A direct laryngoscopy showed a swol-
len epiglottis and left vocal cord palsy. 
The patient was planned for a tracheos-
tomy prior to chemotherapy. Unfortu-
nately, she collapsed in the ward a day 
after admission, was resuscitated, and 
required intensive care unit nursing. A CT 
angiography showed pulmonary embol-
ism involving the right main, ascending 
and descending pulmonary arteries. Her 
stay in the intensive care unit was com-
plicated by bleeding following anticoagu-
lant therapy, a deteriorating renal func-
tion, septicaemia with Staphylococcus 
aureus and hypothyroidism. Her renal 
function deteriorated further and she 
continued to bleed despite continuous 
support with blood products. Her coagu-
lation profile was persistently prolonged 
(PT: 22.4 seconds, INR: 1.85, APTT: 
>180 seconds). CT scan of the brain 
showed gross oedema secondary to hy-
poxic brain injury. She finally succumbed 
to her illness one week post admission. 
 
DISCUSSION 
 
Malignant tumours of the thyroid in gen-
eral are not very common. The incidence 
accounts for 1-2 cases per 100,000 
people (Sippel et al. 2002). Of these,
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Figure 1: Diffuse infiltration of thyroid tissue with lymphoid cells. H&E (x40) 
 
thyroid lymphomas only account for less 
than 5% of thyroid malignancies and 2% 
of all malignant lymphomas (Sippel et al. 
2002). They commonly present with a 
rapidly enlarging neck mass, often caus-
ing obstructive symptoms as in both of 
the cases presented. It occurs more fre-
quently in women than men (Sippel et al. 
2002; Tupchong et al. 1986; Charles et 
al. 2002), in keeping with the predilection 
of thyroid disease for women in general.  
Thyroid lymphoma is frequently asso-
ciated with Hashimoto’s thyroiditis (Abdel 
et al. 2001) which is not evident in both 
cases mentioned. There are however, 
case series which report the association 
of thyroiditis to be between 25-75% 
(Abdel et al. 2001). It is hypothesized that 
chronic antigenic stimulation secondary 
to autoimmune disorders leads to chronic 
proliferation of lymphoid cells, which 
eventually undergo mutation resulting in 
clonal proliferation and development of 
lymphoma (Moshynska & Saxena 2008). 
However, not all patients with Hashi-
moto’s thyroiditis develop lymphoma of 
the thyroid gland.  
The International Prognostic Index (IPI) 
is used to predict the risk of disease re-
currence and overall survival by taking 
into account factors such as age, stage of 
disease, performance status, number of 
extranodal sites, and the presence or ab-
sence of an elevated serum lactate dehy-
drogenase (LDH) (The International Non-
Hodgkin's Lymphoma Prognostic Factors 
Project 1993). This is used generally to 
predict survival in patients with non-Hodg-
kin’s lymphoma. Based on this system, 
both patients described above have an IPI 
score of 2 (age and elevated LDH) which 
places them in the low/intermediate risk. A 
study done by Ha et al. (2001) tested the 
usefulness of the IPI in predicting the 
prognosis of patients with thyroid lym-
phoma. The 5-year survival rate for pa-
tients with an IPI of 0 was 86% versus 
50% for patients with an IPI of greater 
than 0. The data included patients treated 
with radiation alone, chemotherapy alone, 
or combined-modality therapy. A different 
study (Abdel et al. 2001) of 60 patients 
with thyroid lymphoma showed that me-
diastinal involvement and performance 
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status was the most important indepen-
dent prognostic factors influencing re-
lapse-free survival and overall survival. 
Primary thyroid lymphoma is uncom-
mon and its optimum management has 
always been a controversial issue. As the 
number of cases is small, mainly in the 
form of case reports, there is lack of ran-
domized prospective studies and thus 
different treatment protocols are being 
practised. In the past, surgery played a 
major role in the diagnosis and treatment 
of thyroid lymphoma (Abdel et al. 2001). 
This still hold true for cases of localized 
mucosa-associated thyroid (MALT) lym-
phoma where there is a complete re-
sponse rate of more than 90% (Widder & 
Pasieka 2004). Surgery also plays an 
important role in the early control of 
symptoms especially in patients with se-
vere airway obstruction or those with se-
vere pain (Sippel et al. 2002). A retros-
pective study of 46 cases by Tupchong et 
al. (1986) showed that patients with total 
macroscopic removal of the tumour had 
the highest rate of local control and has a 
long survival rate when compared to 
those receiving radiotherapy alone. How-
ever, in these cases the disease was li-
mited to the thyroid and cervical lymph 
nodes. 
The more common type of thyroid lym-
phoma is diffuse large B-cell lymphoma 
(DLBCL) which is aggressive and usually 
presents with disseminated disease as 
shown in the present cases. The surgical 
risks for these patients are considerable 
which includes operative mortality, nerve 
injuries (recurrent laryngeal), hypopara-
thyroidism and possible damage to the 
trachea, esophagus and large vessels. 
With the advent of fine needle aspiration 
cytology, flow cytometry and immuno-
histochemical analysis; it is possible to 
avoid unnecessary surgical intervention 
for tissue diagnosis (Charles et al. 2002). 
Furthermore, combination therapy of 
radiation and chemotherapy without ex-
tensive surgery is associated with an 
equal or a superior 5 year survival rate 
without the additional risks of surgery 
(Abdel et al. 2001).  
In the present cases, both patients un-
derwent emergency thyroidectomy to 
relieve the obstructive symptoms. In the 
first case, the patient received a combi-
nation of rituximab and CHOP. Rituximab 
is a chimeric monoclonal antibody that 
targets CD20 antigen expressed on B-
cells. The use of rituximab in combination 
with the standard chemotherapy protocol 
has been shown to have significant sur-
vival benefit and improvement of patient 
outcome in DLBCL (Feugier et al. 2005). 
In this randomized study, rituximab com-
bined with CHOP was compared to 
CHOP alone in patients aged more than 
60 years with diffuse large B-cell lym-
phoma and CD20-positivity. The combi-
nation of rituximab and CHOP improved 
rates of complete response, failure-free 
survival, and survival. Although this study 
does not look at primary thyroid lym-
phoma per se, it may be assumed that 
rituximab will benefit any lymphomas with 
CD20 positivity as it specifically targets 
these antigens that are present on B-
cells. Our patient received 8 cycles of the 
combination chemotherapy and survived 
for 12 months from the time of presenta-
tion. 
The second case was more compli-
cated since the patient had concomitant 
thrombosis, initially involving the left in-
ternal jugular vein which developed into a 
left subclavian and axillary thrombosis 
post-operatively. Following that, she de-
veloped pulmonary embolism in the 
ward. The acute coronary syndrome that 
she had prior to collapse may have been 
due to another thrombosis within the co-
ronary vessels itself. This added to the 
difficulty in her management. Anticoagu-
lant was needed to prevent further 
thromboembolism but she developed 
bleeding complications. If chemotherapy 
was started earlier, she might have be-
nefited from the reduced tumour burden. 
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The bulk of her tumour may have contri-
buted to the stasis of blood within her 
vessels and caused the repeated epi-
sodes of thrombosis. A second surgery 
was not an option at this time as she was 
haemodynamically unstable. Her progno-
sis may have been better if chemothe-
rapy was started immediately after de-
bulking of her tumour initially. 
 We describe two cases of primary thy-
roid lymphoma that presented with an 
enlarging thyroid mass and had to un-
dergo emergency thyroidectomy. Both 
had similar presentations but with differ-
ent outcomes. Treatment options for pri-
mary thyroid lymphoma include com-
bined therapy with surgery playing a mi-
nimal role for diagnosis but a crucial role 
for compromised airway secondary to an 
enlarging thyroid mass. Addition of a mo-
noclonal antibody may increase survival 
risk for patients who are rapidly diag-
nosed and commenced early treatment. 
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